Loading...

SRRK - Scholar Rock Holding Corporation

Top Biomed Signal for 06-25-2022
Top Biomed Stock Signal: SRRK



Stock Signal Information


Signal

Top Biomed Stock
Report Date: 06-25-2022
Symbol: SRRK - Scholar Rock Holding Corporation
Sector:
Industry:
Top Biomed Stock Signal: SRRK

  SRRK Technical Chart

Company Contact

Scholar Rock Holding Corporation (SRRK)
620 Memorial Dr Fl 2
Cambridge, MASSACHUSETTS 02139
Phone: 18572593860
Website: http://scholarrock.com
CEO: Dr. Nagesh Mahanthappa


Company Profile

Scholar Rock Holding Corp. is a biopharmaceutical company. The company is headquartered in Cambridge, Massachusetts and currently employs 69 full-time employees. The firm is engaged in the development of monoclonal antibodies for treatment of diseases, such as neuromuscular disorders, cancer, fibrosis, and anemia. The firm's lead product candidate is SRK-015 that is in its pre-clinical stage of development. SRK-015 is a selective inhibitor of the activation of the growth factor myostatin in skeletal muscle. The company is used to treat spinal muscular atrophy (SMA). The firm also develops other antibody programs that include TGF?1 and BMP6. The TGF?1 antibody program is focused on the development of antibodies that are specific inhibitors of TGF?1 members.